Literature DB >> 16081426

Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts.

Silvia Svegliati1, Raffaella Cancello, Paola Sambo, Michele Luchetti, Paolo Paroncini, Guido Orlandini, Giancarlo Discepoli, Roberto Paterno, Mariarosaria Santillo, Concetta Cuozzo, Silvana Cassano, Enrico V Avvedimento, Armando Gabrielli.   

Abstract

The levels of Ras proteins in human primary fibroblasts are regulated by PDGF (platelet-derived growth factor). PDGF induced post-transcriptionally Ha-Ras by stimulating reactive oxygen species (ROS) and ERK1/2. Activation of ERK1/2 and high ROS levels stabilize Ha-Ras protein, by inhibiting proteasomal degradation. We found a remarkable example in vivo of amplification of this circuitry in fibroblasts derived from systemic sclerosis (scleroderma) lesions, producing vast excess of ROS and undergoing rapid senescence. High ROS, Ha-Ras, and active ERK1/2 stimulated collagen synthesis, DNA damage, and accelerated senescence. Conversely ROS or Ras inhibition interrupted the signaling cascade and restored the normal phenotype. We conclude that in primary fibroblasts stabilization of Ras protein by ROS and ERK1/2 amplifies the response of the cells to growth factors and in systemic sclerosis represents a critical factor in the onset and progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081426     DOI: 10.1074/jbc.M502851200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.

Authors:  Pei-Suen Tsou; Nadine N Talia; Adam J Pinney; Ann Kendzicky; Sonsoles Piera-Velazquez; Sergio A Jimenez; James R Seibold; Kristine Phillips; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2011-12-12

Review 2.  Recent advances in the treatment of systemic sclerosis.

Authors:  Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 3.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

4.  Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGFβ receptor-JNK1 signalling.

Authors:  Evgeniy Panzhinskiy; W Michael Zawada; Kurt R Stenmark; Mita Das
Journal:  Cardiovasc Res       Date:  2012-06-26       Impact factor: 10.787

5.  Selective protection of nuclear thioredoxin-1 and glutathione redox systems against oxidation during glucose and glutamine deficiency in human colonic epithelial cells.

Authors:  Young-Mi Go; Thomas R Ziegler; Jennifer M Johnson; Li Gu; Jason M Hansen; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2006-11-10       Impact factor: 7.376

6.  Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins.

Authors:  Alessandra Bertoni; Paola Giuliano; Mario Galgani; Deborah Rotoli; Luca Ulianich; Annagrazia Adornetto; Maria Rosaria Santillo; Antonio Porcellini; Vittorio Enrico Avvedimento
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

Review 7.  Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.

Authors:  Alfred Grassegger; Gabriela Pohla-Gubo; Margret Frauscher; Helmut Hintner
Journal:  Wien Med Wochenschr       Date:  2008

8.  Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Marialuisa Bocchino; Savina Agnese; Evelina Fagone; Silvia Svegliati; Domenico Grieco; Carlo Vancheri; Armando Gabrielli; Alessandro Sanduzzi; Enrico V Avvedimento
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

9.  Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans.

Authors:  Waylan K Bessler; Farlyn Z Hudson; Hanfang Zhang; Valerie Harris; Yusi Wang; Julie A Mund; Brandon Downing; David A Ingram; Jamie Case; David J Fulton; Brian K Stansfield
Journal:  Free Radic Biol Med       Date:  2016-06-03       Impact factor: 7.376

10.  Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.

Authors:  A Servettaz; P Guilpain; C Goulvestre; C Chéreau; C Hercend; C Nicco; L Guillevin; B Weill; L Mouthon; F Batteux
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.